J

Juvenescence

38 employees

Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.

Investor insights

Sectors invested in

Biotechnology8
Medical4
Health Care4
Clinical Trials3
Therapeutics3
Pharmaceutical2
fibrosis1
Life Science1
Artificial Intelligence1
aging research1
GANs1
artificial intelligence1
deep learning1
drug discovery1
longevity1
GANs-RL1
reinforcement learning1
Generative adversarial networks1
biomarker development1

Funding rounds participated in

$5M sweet spot round size

Most of their 13 investments are in rounds between $3M and $9M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Biopharma

Date founded

2016

Investments made

M

Morphoceuticals, Inc. raised $8M on January 23, 2023

Investors: Prime Movers Lab and Juvenescence

M

MDI Therapeutics, Inc. raised $9M on March 21, 2022

Investors: Juvenescence

L

LyGenesis raised $11M on December 30, 2020

Investors: Longevity Vision Fund and Juvenescence

L

LyGenesis raised $4M on October 21, 2019

Investors: Longevity Vision Fund and Juvenescence

U

Undisclosed raised $3.5M on May 28, 2019

Investors: Juvenescence

U

Undisclosed raised $1.5M on March 27, 2019

Investors: Juvenescence

U

Undisclosed raised $3M on February 4, 2019

Investors: Juvenescence

A

AgeX Therapeutics, Inc. raised $43M on September 4, 2018

Investors: Juvenescence

U

Undisclosed raised $3M on August 6, 2018

Investors: Juvenescence

U

Undisclosed raised $10M on July 12, 2018

Investors: KIZOO and Juvenescence

FAQ